7 medtech stories we missed this week: June 22, 2018
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation th...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Accuray Inc. Arcuro Medical BTG Masimo MedTech NuSight P Source Type: news

No new trial for Bard in $4m vena cava filter loss
Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard this week failed to win a new trial after a jury awarded nearly $4 million to the plaintiff in a bellwether product liability lawsuit brought over Bard’s inferior vena cava filter. Plaintiff Sherr-Una Booker was implanted in June 2007 with a Bard G2 IVC filter to mitigate her risk of pulmonary embolism during or after a surgery, according to court documents. By 2014 the G2 filter had tilted to penetrate the IVC’s wall and fractured, leaving one strut in Booker’s right atrium. During surgery in July 2014 to remove the filter and stru...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Legal News bectondickinson crbard Source Type: news

VTE Linked to Acute Decline in Physical Function in Women
Greater difference in physical decline for women specifically reporting pulmonary embolism (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 15, 2018 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Oncology, Pulmonology, Journal, Source Type: news

Post-Op VTE Risk Up After Intra-Op Blood Transfusion
(MedPage Today) -- Deep vein thrombosis, pulmonary embolism more common within 30 days (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 14, 2018 Category: Cardiology Source Type: news

XARELTO ® (rivaroxaban) Associated with Significantly Reduced Time in Hospital and Decreased Costs Compared to Standard of Care in New Study of Patients with Low-Risk Pulmonary Embolism (PE)
(Source: Johnson and Johnson)
Source: Johnson and Johnson - June 14, 2018 Category: Pharmaceuticals Source Type: news

Stress echo beats CCTA for evaluating chest pain
Stress echocardiography is a safe method of evaluating chest pain in patients...Read more on AuntMinnie.comRelated Reading: MRA tops CTA for pulmonary embolism evaluation CCTA usage rate rises sharply, but still eclipsed by MPI CCTA predicts heart events in stable chest pain patients Radiologists now use CCTA more than cardiologists do Echo groups release new stress echo guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 13, 2018 Category: Radiology Source Type: news

Serena Williams Battles Pulmonary Embolism and a Hematoma
Title: Serena Williams Battles Pulmonary Embolism and a HematomaCategory: Doctor's& Expert's views on SymptomsCreated: 3/3/2011 12:42:00 PMLast Editorial Review: 6/13/2018 2:55:09 PM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - June 13, 2018 Category: Respiratory Medicine Source Type: news

Life-threatening pulmonary embolism that occurred immediately after acute carbon monoxide poisoning in the emergency department - Lee SJ, Cha YS, Lee Y, Kim H.
We report the first case of a life-threatening PE that occu... (Source: SafetyLit)
Source: SafetyLit - June 11, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Pulmonary thromboembolism after carbon monoxide poisoning: a case series and review of the literature - Lee Y, Lim TH, Kang H, Oh J, Ko BS.
OBJECTIVE: Carbon monoxide (CO) poisoning is known to increase thrombotic tendency, and the risk of deep vein thrombosis in individuals who have experienced CO poisoning is higher than in the general population. However, there are a few reports describing ... (Source: SafetyLit)
Source: SafetyLit - June 11, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Inari Medical wins FDA 510(k) for FlowTriever
Inari Medical said today it won FDA 510(k) clearance for its FlowTriever stent retriever designed to treat pulmonary embolisms. The clearance came based upon results from the company’s Flare clinical study of the device, which examined data from 106 patients with acute pulmonary embolisms treated with the FlowTriever at 18 US sites, the Irvine, Calif.-based company said. Results from the study indicated a decrease in mean RV/LV ratio from baseline of 1.53 to 1.15 at 48 hours post-procedure. Data also indicated excellent safety at 30 days with a 3.8% rate of major adverse events and no device related complication...
Source: Mass Device - May 22, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Regulatory/Compliance Vascular Inari Medical Source Type: news

MRA tops CTA for pulmonary embolism evaluation
MR angiography (MRA) may have an edge over CT angiography (CTA) for diagnosing...Read more on AuntMinnie.comRelated Reading: French find no need for CT to rule out PE CT use for pulmonary embolism rises despite low yield Doctors who order fewer CTPA scans detect more PE Role of imaging modalities is changing for PE diagnosis Video from ECR 2017: Dr. Martine Rémy-Jardin on pulmonary embolism (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 16, 2018 Category: Radiology Source Type: news

May 4, 2018 This Week in Cardiology May 4, 2018 This Week in Cardiology
AHA rescinds sections of the stroke guidelines, thrombectomy for pulmonary embolism, Mitra-clip, nuts and AF, and blood pressure measurements are discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

FLARE: Mechanical Thrombectomy Effective in Intermediate-Risk PE FLARE: Mechanical Thrombectomy Effective in Intermediate-Risk PE
The ability to perform catheter-directed mechanical thrombectomy sans thrombolytics could be a game-changer in the treatment of acute pulmonary embolism, but experts caution it's early days.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 1, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Inari Medical touts FlowTriever pulmonary embolism study data
Inari Medical today presented results from a study of its FlowTriever retrieval and aspiration system designed to treat pulmonary embolism, touting the safety and efficacy of the system. Results were presented by Dr. Thomas Tu of Louisville, Ky.’s Baptist Health at the Scientific Sessions of the Society for Cardiovascular Angiography and Interventions in San Diego, Irvine, Calif.-based Inari Medical said. “The significant improvement in right heart function shown with the FlowTriever system compares very favorably with outcomes of other techniques used to treat PE. At the same time, the impressive safety profil...
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular Inari Medical Source Type: news

She Died After Collapsing on a Plane the Pilot Refused to Divert. Now Her Family Is Suing.
Brittany Oswell died after having a pulmonary embolism in flight. A suit claims American Airlines was negligent and its medical equipment was faulty. (Source: NYT Health)
Source: NYT Health - April 27, 2018 Category: Consumer Health News Authors: MATTHEW HAAG Tags: Airlines and Airplanes Suits and Litigation (Civil) American Airlines Brittany Oswell South Carolina Deaths (Fatalities) Chris Starks Tina Starks Cory Oswell Source Type: news

DVT and Pulmonary Embolism Secondary to Urinary Retention DVT and Pulmonary Embolism Secondary to Urinary Retention
What was the unusual cause of DVT and PE in this elderly patient presenting with leg edema?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 18, 2018 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

DVT More Likely With Varicose Veins
(MedPage Today) -- Pulmonary embolism, PAD also associated in population-based study (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 28, 2018 Category: Cardiology Source Type: news

Rule-Out Criteria Safely Reduced Testing for PE Rule-Out Criteria Safely Reduced Testing for PE
Among very low risk patients seen in emergency departments with suspected pulmonary embolism (PE), the use of PE rule-out criteria did not result in more thromboembolic events in the next 3 months.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 14, 2018 Category: Consumer Health News Tags: Emergency Medicine News Source Type: news

PERC Safely Rules Out Pulmonary Embolism in ED Setting (CME/CE)
(MedPage Today) -- Outcomes among very low-risk patients not inferior to usual care (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 14, 2018 Category: Cardiology Source Type: news

French find no need for CT to rule out PE
French researchers found that a set of clinical criteria was just as accurate...Read more on AuntMinnie.comRelated Reading: CT use for pulmonary embolism rises despite low yield Doctors who order fewer CTPA scans detect more PE Role of imaging modalities is changing for PE diagnosis Video from ECR 2017: Dr. Martine Rémy-Jardin on pulmonary embolism Ultrasound elevates diagnosis of pulmonary embolism (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2018 Category: Radiology Source Type: news

FDA Letter to Health Care Providers: Death and Pulmonary Embolism Related to Extracorporeal Photopheresis (ECP) Treatment https://go.usa.gov/xnHCy   #MedicalDevice
FDA Letter to Health Care Providers: Death and Pulmonary Embolism Related to Extracorporeal Photopheresis (ECP) Treatment https://go.usa.gov/xnHCy  #MedicalDevice (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - February 8, 2018 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

BTG touts one-year follow-up data for Ekos pulmonary embolism therapy
BTG (LON:BTG) touted results today from a one-year follow-up of pulmonary embolism patients who received the company’s Ekos therapy in its Optalyse PE trial. Researchers studied the 12-month outcomes of 101 patients who were treated over a shorter period and with smaller doses of thrombolytic drugs compared to the current standard. Pulmonary embolism patients treated with BTG’s Ekos device and anti-coagulation drugs received therapy in as little as two hours with a tissue plasminogen activator dose as low as 8 mg, the company reported. Get the full story at our sister site, Drug Delivery Business...
Source: Mass Device - February 6, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Pharmaceuticals Wall Street Beat BTG Source Type: news

AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks AbbVie Wins U.S. Trial in Lawsuit Over AndroGel's Risks
A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 31, 2018 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

CT use for pulmonary embolism rises despite low yield
The use of chest CT to spot pulmonary embolism in hospital emergency department...Read more on AuntMinnie.comRelated Reading: Doctors who order fewer CTPA scans detect more PE Imaging lands high on list of overused medical exams Role of imaging modalities is changing for PE diagnosis Video from ECR 2017: Dr. Martine Rémy-Jardin on pulmonary embolism ACP: Routine CT for suspected PE is unnecessary (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2018 Category: Radiology Source Type: news

Pulmonary Embolism (Blood Clot in the Lung)
Title: Pulmonary Embolism (Blood Clot in the Lung)Category: Diseases and ConditionsCreated: 3/20/2008 12:00:00 AMLast Editorial Review: 1/30/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - January 30, 2018 Category: Respiratory Medicine Source Type: news

Fainting Rarely Tied to Blood Clot, Study Finds
A study of more than 1.6 million adults treated in the emergency department after fainting -- medically known as a "syncope" -- found less than 1 percent had a blockage in an artery leading to the lungs, or pulmonary embolism. (Source: WebMD Health)
Source: WebMD Health - January 29, 2018 Category: Consumer Health News Source Type: news

Pulmonary Embolism Causes < 1% of Syncope, Study Confirms
(MedPage Today) -- Rarity of lung clots contradicts PESIT data (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 29, 2018 Category: Cardiology Source Type: news

Pulmonary Embolism Causes < 1% of Syncope in ER, Study Confirms
(MedPage Today) -- Rarity of ER lung clots contradicts PESIT data (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - January 29, 2018 Category: Respiratory Medicine Source Type: news

AbbVie wins U.S. trial in lawsuit over AndroGel's risks
(Reuters) - A federal jury in Chicago on Friday found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company's testosterone replacement medication AndroGel. (Source: Reuters: Health)
Source: Reuters: Health - January 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Higher Use of CT Pulmonary Angiogram Tied to Lower PE Diagnostic Yield
Greater use of computed tomographic pulmonary angiogram (CTPA) is associated with lower diagnostic yield for pulmonary embolism, according to a research letter in JAMA Internal... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 9, 2018 Category: Primary Care Source Type: news

Doctors who order fewer CTPA scans detect more PE
Turns out that less really is more. Canadian researchers are reporting that...Read more on AuntMinnie.comRelated Reading: Ultrasound elevates diagnosis of pulmonary embolism ACP: Routine CT for suspected PE is unnecessary CTPA-based prediction model nails pulmonary hypertension ARRS: Pulmonary MRI feasible for evaluating acute PE CAD may catch missed pulmonary embolism on CTPA studies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 8, 2018 Category: Radiology Source Type: news

FDA issues Class I recall for select J & J Sterilmed Agilis steerable introducer sheaths
The FDA yesterday issued a recall for Johnson & Johnson (NYSE:JNJ) subsidiary Sterilmed’s reprocessed Agilis steerable introducer sheaths over issues with possible air embolisms, labeling the recall as a Class I. Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. Sterilmed’s Agilis steerable introducer sheath is designed for the insertion and positioning of cardiovascular catheters in the heart, including the left side of the heart through the inter...
Source: Mass Device - January 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Food & Drug Administration (FDA) Recalls johnsonandjohnson SterilMed Inc. Source Type: news

RA: Do JAK Inhibitors Increase Blood Clot Risk? RA: Do JAK Inhibitors Increase Blood Clot Risk?
An analysis of postmarket case reports for patients treated with tofacitinib or ruxolitinib hinted at a possible increased risk for pulmonary thrombosis, but not for VTE or PE. Experts are not convinced.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 22, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

ASH: Oral Edoxaban Noninferior to Dalteparin for CA - Linked VTE
Oral edoxaban found noninferior for recurrent venous thromboembolism or major bleeding (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 13, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Oncology, Pharmacy, Pulmonology, Conference News, Source Type: news

How Physicians Perform Prehospital ECMO on the Streets of Paris
The objective of ECPR is to perfuse the brain while the cause of the cardiac arrest is sought and treated at a specialty hospital (e.g., by coronary angiography, CT scan, etc.). Indeed, the primary objective is to obtain return of spontaneous circulation (ROSC), however, long-term survival depends on the neurological prognosis of the patient. (Source: JEMS Patient Care)
Source: JEMS Patient Care - December 2, 2017 Category: Emergency Medicine Authors: Alice Hutin, MD, MSc Tags: Patient Care Cardiac & Resuscitation Source Type: news

A Medical Director's Personal Experience with ECMO Reveals Several Lessons Learned
My personal experience with ED ECMO What does it take to save the life of someone who's in shock and suffering from an acute massive pulmonary embolism? The answer is a comprehensive system of medical care that starts in the field with well-trained providers and is seamlessly backed up by hospitals that can provide highly sophisticated treatments that can now be started in the ED. As a cardiologist and the operational medical director for the city of Richmond, Va., and the surrounding Henrico County, I've had the privilege of helping to develop a comprehensive, regional system of care. In this article, I'm going to use my ...
Source: JEMS Patient Care - December 2, 2017 Category: Emergency Medicine Authors: Joseph P. Ornato, MD, FACP, FACC, FACEP Tags: Patient Care Cardiac & Resuscitation Source Type: news

How Physicians Perform Prehospital ECMO on the Streets of Paris
The objective of ECPR is to perfuse the brain while the cause of the cardiac arrest is sought and treated at a specialty hospital (e.g., by coronary angiography, CT scan, etc.). Indeed, the primary objective is to obtain return of spontaneous circulation (ROSC), however, long-term survival depends on the neurological prognosis of the patient. Once ECPR has been initiated, acceptable blood flow is restored to the whole body, and especially to the brain and coronary arteries in order to limit ischemic consequences. Many studies, both clinical and experimental, have shown that the blood flow delivered by ECPR is much highe...
Source: JEMS Patient Care - December 1, 2017 Category: Emergency Medicine Authors: Alice Hutin, MD, MSc Tags: Patient Care Cardiac & Resuscitation Source Type: news

A Medical Director's Personal Experience with ECMO Reveals Several Lessons Learned
My personal experience with ED ECMO What does it take to save the life of someone who's in shock and suffering from an acute massive pulmonary embolism? The answer is a comprehensive system of medical care that starts in the field with well-trained providers and is seamlessly backed up by hospitals that can provide highly sophisticated treatments that can now be started in the ED. As a cardiologist and the operational medical director for the city of Richmond, Va., and the surrounding Henrico County, I've had the privilege of helping to develop a comprehensive, regional system of care. In this article, I'm going t...
Source: JEMS Patient Care - December 1, 2017 Category: Emergency Medicine Authors: Joseph P. Ornato, MD, FACP, FACC, FACEP Tags: Patient Care Cardiac & Resuscitation Source Type: news

Pradaxa ® gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism
Pradaxa ® gains EU approval for treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

New data on safety and efficacy of Pradaxa ® in treatment of acute deep vein thrombosis and pulmonary embolism
New data on safety and efficacy of Pradaxa ® in treatment of acute deep vein thrombosis and pulmonary embolism (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

New data analyses show consistent efficacy and safety profile of Pradaxa ® in broad range of patients with acute deep vein thrombosis or pulmonary embolism*
New data analyses show consistent efficacy and safety profile of Pradaxa ® in broad range of patients with acute deep vein thrombosis or pulmonary embolism* (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Application submitted to the European Medicines Agency (EMA) for use of Pradaxa ® in treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE
Application submitted to the European Medicines Agency (EMA) for use of Pradaxa ® in treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Boehringer Ingelheim launches RE-COVERY DVT/PE ™: global observational study on management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate)
Boehringer Ingelheim launches RE-COVERY DVT/PE ™: global observational study on management of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with Pradaxa® (dabigatran etexilate) (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

FDA approves Pradaxa ® for treatment and reduction in risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE)
FDA approves Pradaxa ® for treatment and reduction in risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

Positive CHMP opinion for Pradaxa ® in treatment of deep vein thrombosis and pulmonary embolism and prevention of repeat blood clots
Positive CHMP opinion for Pradaxa ® in treatment of deep vein thrombosis and pulmonary embolism and prevention of repeat blood clots (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

New findings from two studies support substantial benefit of Pradaxa ® for prevention of recurrent deep vein thrombosis and pulmonary embolism
New findings from two studies support substantial benefit of Pradaxa ® for prevention of recurrent deep vein thrombosis and pulmonary embolism (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news

French Oncologists Upgrade Mesothelioma Standard of Care
Oncologists throughout France have joined the U.S.-based National Comprehensive Cancer Network (NCCN) in upgrading their recommended standard-of-care treatment regimen for unresectable pleural mesothelioma. Both groups have added bevacizumab (Avastin) to the traditional cisplatin and pemetrexed chemotherapy combination, expecting to see longer patient survival. “This is a major advancement for the care of mesothelioma patients,” Dr. Gerard Zalcman, head of thoracic oncology at Bichat-Claude Bernard Hospital, told Asbestos.com. “Clearly, this drug can change the natural history of this tumor.” Bevaci...
Source: Asbestos and Mesothelioma News - November 20, 2017 Category: Environmental Health Authors: Daniel King Tags: American Society of Clinical Oncology Avastin bevacizumab Bichat-Claude Bernard Hospital French Cooperative Thoracic Intergroup Gerard Zalcman National Comprehensive Cancer Network nintedanib Ofev pleural mesothelioma chemotherapy Source Type: news

General practitioners accurately diagnose DVT with US
General practitioners can be trained in compression ultrasonography to accurately...Read more on AuntMinnie.comRelated Reading: Role of imaging modalities is changing for PE diagnosis Ultrasound elevates diagnosis of pulmonary embolism Can ultrasound for deep vein thrombosis cause a PE? Ultrasound screening catches embolism in cancer patients AAOS includes DVT US on Choosing Wisely list (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 17, 2017 Category: Radiology Source Type: news

New Practice Discharges More Pulmonary Embolism Patients New Practice Discharges More Pulmonary Embolism Patients
A carefully defined group of pulmonary embolism patients can avoid hospitalization, saving healthcare systems time and money, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2017 Category: Consumer Health News Tags: Emergency Medicine News Source Type: news